Literature DB >> 14646389

Increase in serum levels of autoantibodies after attack of seasonal allergic rhinitis in patients with Graves' disease.

Keiko Takeoka1, Yoh Hidaka, Hiroyuki Hanada, Tomoko Nomura, Susumu Tanaka, Toru Takano, Nobuyuki Amino.   

Abstract

BACKGROUND: The prevalence of allergic disease is increasing worldwide, but its influence on the clinical course of autoimmune diseases is unknown.
OBJECTIVE: The purpose of this study was to assess the effect of seasonal allergic rhinitis on the clinical course of Graves' disease, which has been considered a Th2-dominant autoimmune disease.
METHODS: Ten patients with Graves' disease, who were considered to be in a state of remission or near remission, were serially examined for 18 months starting from August. Five of them had seasonal allergic rhinitis due to Japanese cedar pollen, and the remaining patients had no such allergic disorders. Peripheral eosinophil counts, serum concentrations of cedar-pollen-specific IgE, anti-TSH-receptor antibody, anti-thyroid-peroxidase antibody and antithyroglobulin antibody were assessed at 2- to 4-month intervals. Serum thyroid hormones and TSH levels were also measured to evaluate disease activity.
RESULTS: All patients with pollinosis had attacks of allergic rhinitis caused by cedar pollen in early March. Subsequently, peripheral eosinophil counts, pollen-specific IgE activity and serum levels of anti-thyroid-peroxidase and antithyroglobulin autoantibodies markedly increased. Serum levels of anti-TSH-receptor antibody increased in 3 patients in association with an increase in serum thyroid hormones but were always negative in 2 patients. The control patients without pollinosis showed no consistent change of these parameters.
CONCLUSIONS: Seasonal allergic rhinitis aggravated the clinical course of Graves' disease and induced an increase in serum antithyroid autoantibody concentrations as well as an increase in pollen-specific IgE concentration. These data suggest that environmental antigens induce not only local allergic reactions, but also stimulate thyroid immune reactions toward Th2 proliferation, and finally aggravate Th2-dependent autoimmune thyroid disease. Copyright 2003 S. Karger AG, Basel

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14646389     DOI: 10.1159/000074309

Source DB:  PubMed          Journal:  Int Arch Allergy Immunol        ISSN: 1018-2438            Impact factor:   2.749


  7 in total

1.  A case of Graves' disease developing with exacerbation of sarcoidosis.

Authors:  Shinya Makino; Chisako Yagi; Mariko Naka; Sachie Hirose; Masayoshi Fujiwara; Chiho Ohbayashi
Journal:  Sarcoidosis Vasc Diffuse Lung Dis       Date:  2019-05-01       Impact factor: 0.670

2.  THYROTROPIN-RECEPTOR ANTIBODIES, IMMUNOGLOBULIN E AND ANTINUCLEAR ANTIBODIES IN PATIENTS WITH GRAVES' DISEASE AND GRAVES' ORBITOPATHY.

Authors:  M Stoynova; A Shinkov; G Kirilov; R Kovatcheva
Journal:  Acta Endocrinol (Buchar)       Date:  2021 Apr-Jun       Impact factor: 0.877

Review 3.  Hormonal Effects on Asthma, Rhinitis, and Eczema.

Authors:  Natalia Weare-Regales; Sergio E Chiarella; Juan Carlos Cardet; Y S Prakash; Richard F Lockey
Journal:  J Allergy Clin Immunol Pract       Date:  2022-04-15

4.  Complete remission of human parvovirus b19 associated symptoms by loxoprofen in patients with atopic predispositions.

Authors:  Itsuro Kazama; Naoko Sasagawa; Toshiyuki Nakajima
Journal:  Case Rep Med       Date:  2012-04-24

5.  There is no elevation of immunoglobulin e levels in Albanian patients with autoimmune thyroid diseases.

Authors:  Hatixhe Latifi-Pupovci; Besa Gacaferri-Lumezi; Violeta Lokaj-Berisha
Journal:  J Thyroid Res       Date:  2014-05-14

6.  Nonsteroidal Anti-Inflammatory Drugs Quickly Resolve Symptoms Associated with EBV-Induced Infectious Mononucleosis in Patients with Atopic Predispositions.

Authors:  Itsuro Kazama; Chieko Miura; Toshiyuki Nakajima
Journal:  Am J Case Rep       Date:  2016-02-14

7.  Factors Associated With Mortality of Thyroid Storm: Analysis Using a National Inpatient Database in Japan.

Authors:  Yosuke Ono; Sachiko Ono; Hideo Yasunaga; Hiroki Matsui; Kiyohide Fushimi; Yuji Tanaka
Journal:  Medicine (Baltimore)       Date:  2016-02       Impact factor: 1.889

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.